Aerpio Pharmaceuticals financials at a glance
| Year | Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2015 | 2016 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$0.00M | $20.16M | $0.00M | $15.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| GM % | Gross Margin % |
|
0.00% | 100.00% | 0.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| OM | Operating Margin |
|
0.00% | -55.47% | 0.00% | -42.38% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
$0.00 | $0.00 | ||||||
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
26.94m | 40.58m | 40.59m | 47.11m | 47.31m | 0m | 0m | 0m |
| OCF | Operating Cash Flow |
|
$-18.88M | $-5.81M | $-23.85M | $-5.38M | $0.00M | $-17.88M | $-15.72M | $0.00M |
| FCF | Free Cash Flow |
|
$-18.89M | $-6.63M | $-24.09M | $-5.40M | $0.00M | $-17.92M | $-15.83M | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$-0.87 | $-0.17 | $-8.90 | $-1.90 | $0.00 | $-208.66 | $-278.51 | $0.00 |